Rad51L1 (RAD51B) (NM_133509) Human Tagged Lenti ORF Clone from OriGene Technologies

9620 Medical Center Drive # 200

Rockville, Maryland 20850

United States

Phone: 1-888-267-4436 (U.S. only) / 301-340-3188
301-340-9254

(1) An Inducible BRCA1 Expression System with In Vivo Applicability Uncovers Activity of the Combination of ATR and PARP Inhibitors to Overcome Therapy ResistanceCancers (Basel)January 20, 2026Elsa Irving, Alaide Morcavallo, Jekaterina Vohhodina-Tretjakova, Paul W. G. Wijnhoven, Anna L. Beckett, Michael P. Jacques, Rachel S. Evans, Jennifer I. Moss, Anna D. Staniszewska, Josep V. FormentRAD51B (NM_133509) open reading frames (ORFs) were obtained from Genscript (Ohu18572D) and OriGene (RC206457L3), respectively. BRCA1 deletion and mutant constructs were generated using the Q5 site-directed mutagenesis kit

Rad51L1 (RAD51B) (NM_133509) Human Tagged Lenti ORF Clone